Landmark Alzheimer’s Drug Approval Confounds Research Community The US Food and Drug Administration (FDA) approval yesterday of the first new drug for Alzheimer’s disease in 18 years was welcomed by some people looking for hope against an intractable condition. But, for many researchers, it came as a surprise — and
A CRISPR Treatment for Blood Diseases Shows Curative Promise in Small Study Twenty-two patients with inherited blood disorders were free of severe pain and the need for transfusions months after receiving an experimental genome-editing medicine, more evidence the CRISPR-based treatment could be a functional cure. Read more...
Stem Cell Transplant Trial Enrolls First Patient in Minnesota A clinical trial investigating patient-derived stem cell transplants for the treatment of people with severe relapsing forms of multiple sclerosis (MS) has enrolled a patient in Minnesota. Read more...
Microspheres Coated in Stem Cells Could Help Mend Broken Hearts It’s a cruel reality that the heart has such a limited capacity to heal itself, meaning that people who survive heart attacks often go on to have more. Now, researchers at University College London (UCL) have grown heart cells from
CIRM Board Approves New Clinical Trial for ALS The governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $11.99 million to Cedars-Sinai to fund a clinical trial for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. Read more...
Breakthrough Could Lead to Early Detection of Pregnancy Complications The quest to create safer, more successful pregnancies is one of the top goals of modern science. While pregnancy is better understood today than ever before, with improvements in technology helping to lower the risk of negative outcomes, there is much
In Lab, SLU Researchers Find Benefits for Diabetes, Fatty Liver Disease When Combining Two Anti-Diabetes Drugs A Saint Louis University research team, led by Kyle S. McCommis, Ph.D., assistant professor in Biochemistry and Molecular Biology, found that combining two classes of anti-diabetes drugs provides superior benefits in mouse models of
Newly Approved Drug Effective Against Lung Cancer Caused by Genetic Mutation The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The drug is designed to
More Insight on Which Kids Are Most at Risk for Severe COVID-19 Certain underlying medical conditions, as well as complex chronic illnesses exacerbated the risk for severe COVID-19 in children, researchers found in a cross-sectional study. Read more...
Laughing Gas Relieves Symptoms in People with Treatment-Resistant Depression A single, one-hour treatment that involves breathing in a mixture of oxygen and nitrous oxide — otherwise known as laughing gas — significantly improved symptoms in people with treatment-resistant depression, according to new data from researchers at Washington University School of